Predictions
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€53.82
24.02.12
24.02.12
€60.00
25.05.12
25.05.12
0.09%
25.05.12
25.05.12
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€13.97
02.09.11
02.09.11
€17.70
14.02.12
14.02.12
26.78%
14.02.12
14.02.12
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€13.97
02.09.11
02.09.11
€17.70
14.02.12
14.02.12
26.78%
14.02.12
14.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€22.90
02.11.11
02.11.11
€26.67
20.01.12
20.01.12
8.14%
20.01.12
20.01.12
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€50.35
02.10.11
02.10.11
€53.50
28.10.11
28.10.11
6.26%
28.10.11
28.10.11
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€13.88
21.11.10
21.11.10
€22.50
23.05.11
23.05.11
4.14%
23.05.11
23.05.11
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€13.88
21.11.10
21.11.10
€22.50
23.05.11
23.05.11
4.14%
23.05.11
23.05.11
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€13.88
21.11.10
21.11.10
€22.50
23.05.11
23.05.11
4.14%
23.05.11
23.05.11
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€15.52
25.04.10
25.04.10
€22.29
25.10.10
25.10.10
-9.83%
25.10.10
25.10.10
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€15.52
25.04.10
25.04.10
€22.29
25.10.10
25.10.10
-9.83%
25.10.10
25.10.10
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€15.52
25.04.10
25.04.10
€22.29
25.10.10
25.10.10
-9.83%
25.10.10
25.10.10
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued